Found: 15
Select item for more details and to access through your institution.
Tormentic acid inhibits hepatic stellate cells activation via blocking PI3K/Akt/mTOR and NF‐κB signalling pathways.
- Published in:
- Cell Biochemistry & Function, 2021, v. 39, n. 1, p. 77, doi. 10.1002/cbf.3564
- By:
- Publication type:
- Article
Trolline Ameliorates Liver Fibrosis by Inhibiting the NF-κB Pathway, Promoting HSC Apoptosis and Suppressing Autophagy.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 44, n. 2, p. 436, doi. 10.1159/000485009
- By:
- Publication type:
- Article
Didymin Alleviates Hepatic Fibrosis Through Inhibiting ERK and PI3K/Akt Pathways via Regulation of Raf Kinase Inhibitor Protein.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2016, v. 40, n. 6, p. 1422, doi. 10.1159/000453194
- By:
- Publication type:
- Article
Didymin Alleviates Hepatic Fibrosis Through Inhibiting ERK and PI3K/Akt Pathways via Regulation of Raf Kinase Inhibitor Protein.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2016, v. 40, n. 3/4, p. 1422, doi. 10.1159/000453194
- By:
- Publication type:
- Article
Raf Kinase Inhibitory Protein Down-Expression Exacerbates Hepatic Fibrosis In Vivo and In Vitro.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2016, v. 40, n. 1/2, p. 49, doi. 10.1159/000452524
- By:
- Publication type:
- Article
Tormentic Acid Ameliorates Hepatic Fibrosis in vivo by Inhibiting Glycerophospholipids Metabolism and PI3K/Akt/mTOR and NF-κB Pathways: Based on Transcriptomics and Metabolomics.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.801982
- By:
- Publication type:
- Article
Inhibitory effect of total saponins isolated from Taraphochlamys affinis on duck hepatitis B virus replication.
- Published in:
- China Journal of Chinese Materia Medica, 2012, v. 37, n. 3, p. 384, doi. 10.4268/cjcmm20120327
- By:
- Publication type:
- Article
Methyl helicterate inhibits hepatic stellate cell activation through downregulating the ERK1/2 signaling pathway.
- Published in:
- Journal of Cellular Biochemistry, 2019, v. 120, n. 9, p. 14936, doi. 10.1002/jcb.28756
- By:
- Publication type:
- Article
Role of RKIP in human hepatic stellate cell proliferation, invasion, and metastasis.
- Published in:
- Journal of Cellular Biochemistry, 2019, v. 120, n. 4, p. 6168, doi. 10.1002/jcb.27904
- By:
- Publication type:
- Article
Role of RKIP in human hepatic stellate cell proliferation, invasion, and metastasis.
- Published in:
- Journal of Cellular Biochemistry, 2019, v. 120, n. 4, p. 6168, doi. 10.1002/jcb.27904
- By:
- Publication type:
- Article
[Retracted] Inhibition of RKIP aggravates thioacetamide‑induced acute liver failure in mice.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Inhibition of RKIP aggravates thioacetamide-induced acute liver failure in mice.
- Published in:
- Experimental & Therapeutic Medicine, 2018, v. 16, n. 4, p. 2992, doi. 10.3892/etm.2018.6542
- By:
- Publication type:
- Article
Didymin Ameliorates Liver Fibrosis by Alleviating Endoplasmic Reticulum Stress and Glycerophospholipid Metabolism: Based on Transcriptomics and Metabolomics.
- Published in:
- Drug Design, Development & Therapy, 2022, v. 16, p. 1713, doi. 10.2147/DDDT.S351092
- By:
- Publication type:
- Article
The Regulatory Mechanism of Smilax China L. Saponins against Nonalcoholic Fatty Liver Is Revealed by Metabolomics and Transcriptomics.
- Published in:
- Journal of Oleo Science, 2024, v. 73, n. 5, p. 695, doi. 10.5650/jos.ess23167
- By:
- Publication type:
- Article
Integrative Analysis of Transcriptome and Metabolome to Illuminate the Protective Effects of Didymin against Acute Hepatic Injury.
- Published in:
- Mediators of Inflammation, 2023, p. 1, doi. 10.1155/2023/6051946
- By:
- Publication type:
- Article